BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thapa D, Cairns EA, Szczesniak AM, Toguri JT, Caldwell MD, Kelly MEM. The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation. Cannabis Cannabinoid Res 2018;3:11-20. [PMID: 29450258 DOI: 10.1089/can.2017.0041] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Chan-Hosokawa A, Nguyen L, Lattanzio N, Adams WR. Emergence of Delta-8 Tetrahydrocannabinol (THC) in DUID Investigation Casework: Method Development, Validation and Application. J Anal Toxicol 2021:bkab029. [PMID: 33754645 DOI: 10.1093/jat/bkab029] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Tran BN, Maass M, Musial G, Stern ME, Gehlsen U, Steven P. Topical application of cannabinoid-ligands ameliorates experimental dry-eye disease. Ocul Surf 2021;23:131-9. [PMID: 34922011 DOI: 10.1016/j.jtos.2021.12.008] [Reference Citation Analysis]
3 Khoury M, Cohen I, Bar-sela G. “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained. Pharmaceutics 2022;14:389. [DOI: 10.3390/pharmaceutics14020389] [Reference Citation Analysis]
4 Bielory L, Tabliago NRA. Flavonoid and cannabinoid impact on the ocular surface. Curr Opin Allergy Clin Immunol 2020;20:482-92. [PMID: 32796166 DOI: 10.1097/ACI.0000000000000673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mlost J, Bryk M, Starowicz K. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action. Int J Mol Sci 2020;21:E8870. [PMID: 33238607 DOI: 10.3390/ijms21228870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
6 Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C. Cannabinoids: Therapeutic Use in Clinical Practice. IJMS 2022;23:3344. [DOI: 10.3390/ijms23063344] [Reference Citation Analysis]
7 Gorberg V, Borisov V, Greig IR, Pertwee RG, McCaffery P, Anavi-Goffer S. Motor-like Tics are Mediated by CB2 Cannabinoid Receptor-dependent and Independent Mechanisms Associated with Age and Sex. Mol Neurobiol 2022. [PMID: 35666403 DOI: 10.1007/s12035-022-02884-6] [Reference Citation Analysis]
8 Scheau C, Caruntu C, Badarau IA, Scheau AE, Docea AO, Calina D, Caruntu A. Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier. J Pers Med 2021;11:494. [PMID: 34072930 DOI: 10.3390/jpm11060494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Marsh DT, Smid SD. Cannabis Phytochemicals: A Review of Phytocannabinoid Chemistry and Bioactivity as Neuroprotective Agents. Aust J Chem 2021;74:388. [DOI: 10.1071/ch20183] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Henshaw FR, Dewsbury LS, Lim CK, Steiner GZ. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies. Cannabis Cannabinoid Res 2021;6:177-95. [PMID: 33998900 DOI: 10.1089/can.2020.0105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Lafreniere JD, Kelly MEM. Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options. Neuronal Signal 2018;2:NS20170144. [PMID: 32714590 DOI: 10.1042/NS20170144] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Taskar P, Adelli G, Patil A, Lakhani P, Ashour E, Gul W, ElSohly M, Majumdar S. Analog Derivatization of Cannabidiol for Improved Ocular Permeation. J Ocul Pharmacol Ther 2019;35:301-10. [PMID: 30998110 DOI: 10.1089/jop.2018.0141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Kanabus J, Bryła M, Roszko M, Modrzewska M, Pierzgalski A. Cannabinoids-Characteristics and Potential for Use in Food Production. Molecules 2021;26:6723. [PMID: 34771132 DOI: 10.3390/molecules26216723] [Reference Citation Analysis]
14 Wang MTM, Danesh-Meyer HV. Cannabinoids and the eye. Surv Ophthalmol 2021;66:327-45. [PMID: 32763339 DOI: 10.1016/j.survophthal.2020.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Spyridakos D, Papadogkonaki S, Dionysopoulou S, Mastrodimou N, Polioudaki H, Thermos K. Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement. Neurochem Int 2021;142:104907. [PMID: 33220388 DOI: 10.1016/j.neuint.2020.104907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Cabañero D, Martín-García E, Maldonado R. The CB2 cannabinoid receptor as a therapeutic target in the central nervous system. Expert Opin Ther Targets 2021;25:659-76. [PMID: 34424117 DOI: 10.1080/14728222.2021.1971196] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Talley-Bruns RC, Shatkin MS, Dhar Y, Zelicof SB. The Physiological Effects, Including Risks and Potential Benefits, of Cannabis for Patients Undergoing Elective Orthopedic Procedures. Orthopedics 2021;44:e314-9. [PMID: 33561869 DOI: 10.3928/01477447-20210201-03] [Reference Citation Analysis]
18 Clayton P, Subah S, Venkatesh R, Hill M, Bogoda N. Palmitoylethanolamide: A Potential Alternative to Cannabidiol. J Diet Suppl 2021;:1-26. [PMID: 34842030 DOI: 10.1080/19390211.2021.2005733] [Reference Citation Analysis]
19 Thapa D, Cairns EA, Szczesniak AM, Kulkarni PM, Straiker AJ, Thakur GA, Kelly MEM. Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation. Molecules 2020;25:E417. [PMID: 31968549 DOI: 10.3390/molecules25020417] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
20 Ciolino LA, Ranieri TL, Brueggemeyer JL, Taylor AM, Mohrhaus AS. EVALI Vaping Liquids Part 1: GC-MS Cannabinoids Profiles and Identification of Unnatural THC Isomers. Front Chem 2021;9:746479. [PMID: 34631667 DOI: 10.3389/fchem.2021.746479] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Johnson-Arbor K, Smolinske S. The current state of delta-8 THC. Am J Emerg Med 2021:S0735-6757(21)00552-0. [PMID: 34247877 DOI: 10.1016/j.ajem.2021.06.066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
22 Stella B, Baratta F, Della Pepa C, Arpicco S, Gastaldi D, Dosio F. Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain. Drugs 2021;81:1513-57. [PMID: 34480749 DOI: 10.1007/s40265-021-01579-x] [Reference Citation Analysis]
23 Nguyen AX, Wu AY. Cannabis and the Cornea. Ocul Immunol Inflamm 2020;:1-6. [PMID: 32159404 DOI: 10.1080/09273948.2020.1726969] [Reference Citation Analysis]
24 Nichols JM, Kaplan BLF. Immune Responses Regulated by Cannabidiol. Cannabis Cannabinoid Res 2020;5:12-31. [PMID: 32322673 DOI: 10.1089/can.2018.0073] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 26.5] [Reference Citation Analysis]
25 Lowe H, Toyang N, Steele B, Bryant J, Ngwa W. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases. Int J Mol Sci 2021;22:9472. [PMID: 34502379 DOI: 10.3390/ijms22179472] [Reference Citation Analysis]
26 Kaplan JS, Wagner JK, Reid K, McGuinness F, Arvila S, Brooks M, Stevenson H, Jones J, Risch B, McGillis T, Budinich R, Gambell E, Predovich B. Cannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity, Anxiety, and Spatial Memory. Front Behav Neurosci 2021;15:711639. [PMID: 34512286 DOI: 10.3389/fnbeh.2021.711639] [Reference Citation Analysis]
27 Wu J, Chen N, Liu Y, Godlewski G, Kaplan HJ, Shrader SH, Song ZH, Shao H. Studies of involvement of G-protein coupled receptor-3 in cannabidiol effects on inflammatory responses of mouse primary astrocytes and microglia. PLoS One 2021;16:e0251677. [PMID: 33984046 DOI: 10.1371/journal.pone.0251677] [Reference Citation Analysis]
28 Aiello F, Gallo Afflitto G, Li JO, Martucci A, Cesareo M, Nucci C. CannabinEYEds: The Endocannabinoid System as a Regulator of the Ocular Surface Nociception, Inflammatory Response, Neovascularization and Wound Healing. J Clin Med 2020;9:E4036. [PMID: 33327429 DOI: 10.3390/jcm9124036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Scuteri D, Rombolà L, Hamamura K, Sakurada T, Watanabe C, Sakurada S, Guida F, Boccella S, Maione S, Gallo Afflitto G, Nucci C, Tonin P, Bagetta G, Corasaniti MT. Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence. Biomed Pharmacother 2021;146:112505. [PMID: 34891121 DOI: 10.1016/j.biopha.2021.112505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Chen X, Cowan A, Inan S, Geller EB, Meissler JJ, Rawls SM, Tallarida RJ, Tallarida CS, Watson MN, Adler MW, Eisenstein TK. Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB1 and CB2 receptors. Br J Pharmacol 2019;176:3378-89. [PMID: 31218677 DOI: 10.1111/bph.14769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Rebibo L, Frušić-Zlotkin M, Ofri R, Nassar T, Benita S. The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure. Int J Pharm 2022;:121627. [PMID: 35245638 DOI: 10.1016/j.ijpharm.2022.121627] [Reference Citation Analysis]
32 An D, Peigneur S, Hendrickx LA, Tytgat J. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. Int J Mol Sci 2020;21:E5064. [PMID: 32709050 DOI: 10.3390/ijms21145064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
33 Melik Parsadaniantz S, Rostène W, Baudouin C, Réaux-Le Goazigo A. [Understanding chronic ocular pain]. Biol Aujourdhui 2018;212:1-11. [PMID: 30362450 DOI: 10.1051/jbio/2018017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Conceição Souza M, Cruz Rosas E. Cannabinoid Receptors as Regulators of Neutrophil Activity in Inflammatory Diseases. In: Khajah M, editor. Neutrophils. IntechOpen; 2019. [DOI: 10.5772/intechopen.81995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Carvalho RK, Rocha TL, Fernandes FH, Gonçalves BB, Souza MR, Araújo AA, Barbosa CC, Silva DM, Campos HM, Tomazett MV, Ghedini PC, Guimarães FS, Andersen ML, Santos FCA, Mazaro-Costa R. Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: New insights of cannabidiol-mediated male reproductive toxicity. Chem Biol Interact 2021;351:109743. [PMID: 34774840 DOI: 10.1016/j.cbi.2021.109743] [Reference Citation Analysis]
36 Gray ME, Meehan J, Blair EO, Ward C, Langdon SP, Morrison LR, Marland JRK, Tsiamis A, Kunkler IH, Murray A, Argyle D. Biocompatibility of common implantable sensor materials in a tumor xenograft model. J Biomed Mater Res B Appl Biomater 2019;107:1620-33. [PMID: 30367816 DOI: 10.1002/jbm.b.34254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]